Incyclinide phase 2 for acne

Formerly known as COL-3, Incyclinide will start a new Phase 2, double-blinded, placebo-controlled trial to find the best treatment dose. This trial will evaluate 300 patients for moderate to severe acne. A recent Phase 2 Clinical Trial showed some promise for inflammatory lesions in rosacea.

Incyclinide is a chemically modified tetracycline, modified to retain non-antibiotic properties that may make them effective in treating diseases involving inflammation and/or destruction of the body’s connective tissues.

• Press Release

Related Articles:

• Incyclinide (CollaGenex) gets NIH Funding
• COL-3 new tetracycline derivative being studied
• low dose doxycycline hyclate (SDD)
• Subantimicrobial Dose Doxycycline for Acne and Rosacea
• Periostat (doxycycline) goes generic, get ready for Oracea
• incyclinide targets conditions other than rosacea
• how do tetracyclines help rosacea ?
• incyclinide fails for rosacea, acne still possible

Read more about: tetracyclines